定量病理学が明かすレビー小体病の認知症リスク：APOE遺伝子型ごとの個別化戦略へ

MedAI Digest (JA)
MedAI Digest (JA)
定量病理学が明かすレビー小体病の認知症リスク：APOE遺伝子型ごとの個別化戦略へ
Loading
/

死後脳の定量的分析により、APOE遺伝子型によってレビー小体病の認知症の起こり方がまったく異なることが見えてきた。つまり、人の遺伝的背景に応じた、より個別的な治療の道が開ける可能性があるわけだ。

Original paper: Quantitative pathology and APOE genotype reveal dementia risk and progression in Lewy body disease. — Brain : a journal of neurology. 10.1093/brain/awag114

📄 記事を読む

Leave a Reply

Your email address will not be published. Required fields are marked *

CAPTCHA


Trending now

Quantitative pathology and APOE genotype reveal dementia risk and progression in Lewy body disease.
APOE Genotype and Protein Pathology Shape Dementia Risk in Lewy Body Disease
Transfer-learning guided design of high-performance conjugated polymers for low-voltage electrochemical transistors.
Machine Learning Accelerates Discovery of Ultra-Low-Voltage Polymers
AI-guided multi-omics analysis identifies NPC1-modulated susceptibility to SARS-CoV-2 infection under PM2.5 exposure.
Air Pollution and COVID-19: How NPC1 Mediates SARS-CoV-2 Infection Risk
Personalized artificial intelligence based left ventricular ejection fraction and systolic dysfunction assessment.
ECG-Based AI Models Enable Cost-Effective Cardiac Function Assessment